Tag: Daclizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Daclizumab

Biogen Inc (BIIB) Stake Lifted by ADAMCAPITAL Gestao de Recursos Ltda.

Added to Collection on: 2019-02-18 13:37:30

Tags for this article:

Money
Finance
Economy
Stock market
Stock
Short
Corporate finance
Biogen Inc.
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
WINTON GROUP Ltd Has $234000 Stake in Biogen Inc (BIIB)

Added to Collection on: 2019-02-26 00:31:13

Tags for this article:

Money
Finance
Economy
Stock
Short
Biogen Inc.
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
What Will Happen to Biogen Inc. (BIIB) Next? The Stock Just Declined A Lot

Added to Collection on: 2019-03-21 02:31:21

Tags for this article:

NASDAQ
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab
Aducanumab
Nusinersen
Drugs
Immunosuppressants
Orphan drugs
Genentech
Infliximab

Click the tags to see associated articles and topics

View Article Details
Biogen (BIIB) Stock Rating Maintained at Cowen & Co.; The $275 Target Indicates 20.70 ...

Added to Collection on: 2019-03-20 23:22:30

Tags for this article:

NASDAQ
Samsung
Biogen
Spinal muscular atrophy
Finisar
Monoclonal antibodies
Daclizumab
Aducanumab
Nusinersen
Drugs
Industries
Cowen & Co.
Companies

Click the tags to see associated articles and topics

View Article Details
Mizuho Gives Biogen (BIIB) $235 Target; Mackay Shields Raised News New (NWSA) Position

Added to Collection on: 2019-03-21 22:15:00

Tags for this article:

NASDAQ
Samsung
NASDAQ-100
News Corporation
News Corp
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab
Aducanumab
Nusinersen
Drugs
Companies
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
EPS for Biogen Inc. (BIIB) forecasted at $6.90

Added to Collection on: 2019-03-26 02:22:30

Tags for this article:

NASDAQ
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab
Aducanumab
Drugs
Immunosuppressants
Orphan drugs
Rituximab
Genentech
Infliximab

Click the tags to see associated articles and topics

View Article Details
Biogen Inc. (NASDAQ:BIIB) has analysts on the Bullish side this week.

Added to Collection on: 2019-03-27 04:18:36

Tags for this article:

Finance
Economy
NASDAQ
Short
Biogen
Spinal muscular atrophy
Monoclonal antibodies
Daclizumab

Click the tags to see associated articles and topics

View Article Details
Fresh Stock News: NVIDIA Corporation, (NASDAQ:NVDA), AbbVie, (NYSE:ABBV), Eldorado Gold ...

Added to Collection on: 2020-07-30 15:18:45

Tags for this article:

Companies
AbbVie
Daclizumab
NVDA
Tegra
Nvidia
HYP
Drugs
Health care

Click the tags to see associated articles and topics

View Article Details
Biogen chases rivals with another bet on emerging class of multiple sclerosis drugs

Added to Collection on: 2021-07-13 15:45:00

Tags for this article:

Life Sciences
Health care
Companies
Monoclonal antibodies
Spinal muscular atrophy
Biogen
Dimethyl fumarate
Sanofi
Bruton's tyrosine kinase
Aducanumab
Interferon beta-1a
Daclizumab

Click the tags to see associated articles and topics

View Article Details
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AbbVie Inc. Investors with ...

Added to Collection on: 2022-04-08 22:28:41

Tags for this article:

Life Sciences
Health care
Biotechnology
Immunosuppressants
Monoclonal antibodies
Daclizumab
Biogen
AbbVie
Interferon beta-1a
Forward-looking statement
Multiple sclerosis
European Medicines Agency

Click the tags to see associated articles and topics

View Article Details